论文信息 - Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations. - 字舞流文

Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations.

R. Chiari | V. Ludovini | G. Metro | A. Sidoni | A. Rebonato | B. Ricciuti | S. Baglivo | M. Brambilla | D. Maiettini | A. Siggillino | M. S. Reda